Filing summary: Foley Trasimene Acquisition Corp. (FTAC), Q1 2021
Entity note: Although the request metadata names Alight, this 10-Q is filed by Foley Trasimene Acquisition Corp., a SPAC. It reports the quarter ended March 31, 2021; the statements are unaudited. Alight is discussed as the target of a pending business combination, not as the reporting company.
Business context and reporting period
FTAC had not begun operating activities or generating operating revenue. Its activity consisted of SPAC formation, IPO-related matters, and seeking a business combination. On January 25, 2021, FTAC agreed to combine with Alight and related entities in an intended Up-C structure. The transaction had not closed as of the reporting period.
Financial results and position
| Metric | Q1 2021 / March 31, 2021 | Comparison / context |
|---|---|---|
| Operating revenue | None | FTAC said it did not expect operating revenue until after a business combination. |
| Formation and G&A expenses | $3.26 million | Compared with $959 from inception through March 31, 2020, a period of only several days. |
| Net income | $78.08 million | Primarily reflected noncash gains on warrant and forward purchase agreement (FPA) liabilities. |
| Noncash fair-value gains | $46.92 million on warrants; $34.31 million on FPAs | These gains were partly offset by operating expenses and taxes; they are not operating cash generation. |
| Trust-account interest | $136,051 | Trust assets totaled $1.036 billion at quarter-end. |
| Cash from operating activities | Used $260,347 | No investing or financing cash flows were reported for the quarter. |
| Cash outside the trust | $236,123 on the balance sheet | The cash-flow statement reports ending cash of $236,124; the filing text does not reconcile the $1 difference. |
| Working capital | Deficit of approximately $5.68 million | Management said sponsor funding was available to meet needs through a business combination or for at least one year from issuance of the statements. |
| Liabilities and debt | Total liabilities $142.77 million; no long-term debt reported | Includes $80.47 million warrant liability, $19.97 million FPA liability, and $36.23 million deferred underwriting fee payable, payable only if a business combination closes. |
Redeemable Class A shares classified as temporary equity were $888.63 million, representing 88,863,472 shares at $10.00 each. Total stockholders’ equity was $5.00 million. The reported basic and diluted earnings per share were $0.00 for redeemable Class A and $3.02 for non-redeemable Class B.
Material changes versus the prior comparable period
Q1 2021 net income of $78.08 million contrasts with a $959 net loss reported from inception through March 31, 2020, but that prior period covered only March 26–31, 2020 and is not a meaningful full-quarter comparison. The filing attributes the large 2021 income principally to noncash liability remeasurement gains. The warrant liability fell from $127.39 million at December 31, 2020 to $80.47 million at March 31, 2021; the FPA liability fell from $54.28 million to $19.97 million. Public shares subject to possible redemption increased from 81.06 million to 88.86 million.
Outlook, transaction terms, risks, and unusual items
- Management expected the pending Alight combination to close in Q2 2021, subject to required approvals and other conditions; this was a forecast, not a completed transaction.
- The transaction required, among other conditions, at least $2.6 billion of available cash for Alight and related sellers, at least $5,000,001 of FTAC net tangible assets, stockholder approval, regulatory clearances, and an effective registration statement.
- Two FPAs contemplated purchases totaling $300 million at closing: 30 million Class A shares and 10 million warrants. Public shareholders could redeem shares in connection with a business combination; warrants had no such redemption right.
- FTAC had until May 29, 2022 to complete a business combination. If unsuccessful, it would cease operations and redeem public shares from the trust, subject to stated terms; warrants could expire worthless.
- COVID-19 could adversely affect the search or transaction process, though the specific effect was not determinable. Management also warned that redemptions, additional equity issuance, or debt financing could affect liquidity, dilution, and shareholder value.
- Disclosure controls were concluded to be ineffective because of a material weakness in accounting for warrants and FPAs as liabilities rather than equity. Management reported remediation steps, including enhanced review of complex accounting. No material change in internal control had occurred during the quarter.
- The company reported no material market or interest-rate risk at quarter-end, citing short-term U.S. Treasury and money-market investments.
Important facts for investors to verify
- Confirm the transaction’s closing status and whether the $2.6 billion available-cash condition and other closing conditions were met.
- Review the final transaction consideration, post-closing ownership and dilution, including sponsor conversion terms, FPA securities, and public-share redemptions.
- Assess the sustainability of reported earnings: most Q1 net income came from noncash fair-value gains, not operating revenue or cash flow.
- Monitor the warrant and FPA valuation assumptions, which include Level 3 inputs, and progress in remediating the material weakness.
- Reconcile the $1 difference between balance-sheet cash and cash-flow statement ending cash, and confirm liquidity available outside the trust.